Benefit of Paint Diodlasercoagulation in the Treatment of ROP
Authors:
D. Tomčíková; Z. Prepiaková; B. Kostolná; A. Gerinec
Authors‘ workplace:
Klinika detskej oftalmológie DFNsP-LFUK, Bratislava, prednosta prof. MUDr. A. Gerinec, CSc.
Published in:
Čes. a slov. Oftal., 67, 2011, No. 4, p. 115-118
Category:
Original Article
Overview
Purpose:
Authors compare results of ROP treatment with a single spot diodlasercoagulation (DLC) versus paint – DLC.
Methods:
A retrospective chart review of patients with threshold retinopathy of prematurity treated between 2001–2010 was conducted.
A single spot DLC was used from January 2001 to May 2008. In this group (S I) there were 338 patients (671 eyes) with ROP. In the second group (S II) since June 2008 to June 2010 we have used the paint DLC in 158 patients (316 eyes). Authors compare the need for reoperations to achieve regression of ROP in both groups. Rate of progression, frequency of retreatment, complications and structural outcomes were evaluated.
Results:
In S I was retreatment only with DLC necessary in 43 eyes (6.4 %). Additional cryotherapy was used in 22 eyes (3.3 %). A scleral buckling was used in 107 eyes (15.9 %). In S II was retreatment with DLC used in 4 eyes (1.3 %), the additional cryotherapy in 6 eyes (1.9 %) and the scleral buckling in 11 eyes (3.5 %).
Conclusion:
According to our outcomes we have found out the paint DLC mode is more effective than the single spot DLC in the ROP treatment.
Key words:
retinopathy of prematurity, diodlasercoagulation, single spot diodlasercoagulation, confluent (paint) diodlasercoagulation, retreatment
Sources
1. Banach M.J., Ferrone, P.J., Trese, M.T.: A comparison of dense versus less dense diode laser photocoagulation patterns for threshold retinopathy of prematurity, Ophthalmology, 2000; 107: 324–328.
2. Banach M.J., Berinstein, D.M.: Laser therapy for retinopathy of prematurity, Current Opinion in Ophtalmology 2001; 12:164–170.
3. Early Treatment for Retinopathy of Prematurity Cooperative Group. Revised indications for the treatment of retinopathy of prematurity: results of the Early Treatment for Retinopathy of Prematurity Randomised Trial. Arch Ophtalmol, 2003; 121: 1684–1694.
4. Gonzales, V.H., Giuliari, G.P., Banda , R.M., Guell, D.A., Wingard, M.: Confluent Laser Photocoagulation for the Treatment of Retinopathy of Prematurity, J Pediatr Ophtalmol Strabismus, 2010; 47(2): 81–85.
5. Good, W.V., Hardy, R.J., Dobson, V.: Early Treatment for Retinopathy of Prematurity Cooperative Group. The incidence and course of retinopathy of prematurity: findings from Early Treatment for Retinopathy of Prematurity Study. Pediatrics, 2005; 116: 15–23.
6. International Committee for the Clasification of Retinopathy of Prematurity. The International Classification of Retinopathy of Prematurity revisited. Arch Ophthalmol, 2005; 123: 991–999.
7. Linghun, K., Mintz-Hintzer, A.H.: Intravitreal Bevacizumab as Anti-Vascular Endothelial Growth Factor Therapy for Retinopathy of Prematurity: A Morfologic Study. Arch Ophthalmol, 2008; 126(8): 1161–1163.
8. Mintz-Hinder H.A., Kuffel, R.R.: Intravitreal injection of Bevacizumab (Avastin) for treatment of stage 3 Retinopathy of Prematurity in Zone I or posterior Zone II. Retina 2008; 28: 831–838.
9. Palmer, E.A., Flynn, J.T., Hardy, R.J.: Incidence and early course of retinopathy of prematurity. The Cryotherapy for Reinopathy of Prematurity Cooperative Group. Ophthalmology 1991; 98: 1628–1640.
10. Paysse E.A., Hussein, M.A., Miller, A.M., et al: Pulsed mode versus near continuous mode delivery of diode laser photocoagulation for high – risk retinopathy of prematurity. JAAPOS, 2007; 11: 388–392.
Labels
OphthalmologyArticle was published in
Czech and Slovak Ophthalmology
2011 Issue 4
Most read in this issue
- Unilateral Cystoid Macular Edema Induced by Citalopram – a Case Report
- Morphologic Changes of Anterior Segment of the Eye after Cataract Surgery
- Long Term Results of Laser Refractive Operations – Methods Epi-LASIK or LASEK
- Retinitis Septica Roth – a Case Report